BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 25651180)

  • 1. LRP5 regulates human body fat distribution by modulating adipose progenitor biology in a dose- and depot-specific fashion.
    Loh NY; Neville MJ; Marinou K; Hardcastle SA; Fielding BA; Duncan EL; McCarthy MI; Tobias JH; Gregson CL; Karpe F; Christodoulides C
    Cell Metab; 2015 Feb; 21(2):262-273. PubMed ID: 25651180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LRP6 mediates Wnt/β-catenin signaling and regulates adipogenic differentiation in human mesenchymal stem cells.
    Peröbner I; Karow M; Jochum M; Neth P
    Int J Biochem Cell Biol; 2012 Nov; 44(11):1970-82. PubMed ID: 22871567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New explanation for autosomal dominant high bone mass: Mutation of low-density lipoprotein receptor-related protein 6.
    Whyte MP; McAlister WH; Zhang F; Bijanki VN; Nenninger A; Gottesman GS; Lin EL; Huskey M; Duan S; Dahir K; Mumm S
    Bone; 2019 Oct; 127():228-243. PubMed ID: 31085352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pravastatin prevents steroid-induced osteonecrosis in rats by suppressing PPARγ expression and activating Wnt signaling pathway.
    Jiang Y; Zhang Y; Zhang H; Zhu B; Li P; Lu C; Xu Y; Chen W; Lin N
    Exp Biol Med (Maywood); 2014 Mar; 239(3):347-55. PubMed ID: 24510055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposing Roles of Wnt Inhibitors IGFBP-4 and Dkk1 in Cardiac Ischemia by Differential Targeting of LRP5/6 and β-catenin.
    Wo D; Peng J; Ren DN; Qiu L; Chen J; Zhu Y; Yan Y; Yan H; Wu J; Ma E; Zhong TP; Chen Y; Liu Z; Liu S; Ao L; Liu Z; Jiang C; Peng J; Zou Y; Qian Q; Zhu W
    Circulation; 2016 Dec; 134(24):1991-2007. PubMed ID: 27803037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Catenin-dependent pathway activation by both promiscuous "canonical" WNT3a-, and specific "noncanonical" WNT4- and WNT5a-FZD receptor combinations with strong differences in LRP5 and LRP6 dependency.
    Ring L; Neth P; Weber C; Steffens S; Faussner A
    Cell Signal; 2014 Feb; 26(2):260-7. PubMed ID: 24269653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cartilage oligomeric matrix protein is differentially expressed in human subcutaneous adipose tissue and regulates adipogenesis.
    Denton N; Pinnick KE; Karpe F
    Mol Metab; 2018 Oct; 16():172-179. PubMed ID: 30100245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal hematopoiesis and lack of β-catenin activation in osteoblasts of patients and mice harboring Lrp5 gain-of-function mutations.
    Galán-Díez M; Isa A; Ponzetti M; Nielsen MF; Kassem M; Kousteni S
    Biochim Biophys Acta; 2016 Mar; 1863(3):490-498. PubMed ID: 26681532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RSPO3 impacts body fat distribution and regulates adipose cell biology in vitro.
    Loh NY; Minchin JEN; Pinnick KE; Verma M; Todorčević M; Denton N; Moustafa JE; Kemp JP; Gregson CL; Evans DM; Neville MJ; Small KS; McCarthy MI; Mahajan A; Rawls JF; Karpe F; Christodoulides C
    Nat Commun; 2020 Jun; 11(1):2797. PubMed ID: 32493999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TCF7L2 plays a complex role in human adipose progenitor biology, which might contribute to genetic susceptibility to type 2 diabetes.
    Verma M; Loh NY; Sabaratnam R; Vasan SK; van Dam AD; Todorčević M; Neville MJ; Toledo E; Karpe F; Christodoulides C
    Metabolism; 2022 Aug; 133():155240. PubMed ID: 35697299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of the Wnt/β-catenin pathway and LRP5 protein in bone metabolism of postmenopausal women.
    Kamiński A; Karasiewicz M; Bogacz A; Dziekan K; Seremak-Mrozikiewicz A; Czerny B
    Adv Clin Exp Med; 2019 Feb; 28(2):179-184. PubMed ID: 29963786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-LRP5/6 VHHs promote differentiation of Wnt-hypersensitive intestinal stem cells.
    Fenderico N; van Scherpenzeel RC; Goldflam M; Proverbio D; Jordens I; Kralj T; Stryeck S; Bass TZ; Hermans G; Ullman C; Aastrup T; Gros P; Maurice MM
    Nat Commun; 2019 Jan; 10(1):365. PubMed ID: 30664649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Huogu I formula prevents steroid-induced osteonecrosis in rats by down-regulating PPARgamma expression and activating wnt/LRP5/ beta-catenin signaling.
    Jiang Y; Liu D; Kong X; Xu Y; Chen W; Lin N
    J Tradit Chin Med; 2014 Jun; 34(3):342-50. PubMed ID: 24992763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of low-density lipoprotein-related receptor 5 inhibits liver Cancer cell proliferation via destabilizing Nucleoporin 37.
    Chen J; Wo D; Ma E; Yan H; Peng J; Zhu W; Fang Y; Ren DN
    Cell Commun Signal; 2019 Dec; 17(1):174. PubMed ID: 31881970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt-Lrp5 signaling regulates fatty acid metabolism in the osteoblast.
    Frey JL; Li Z; Ellis JM; Zhang Q; Farber CR; Aja S; Wolfgang MJ; Clemens TL; Riddle RC
    Mol Cell Biol; 2015 Jun; 35(11):1979-91. PubMed ID: 25802278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of the Wnt/LRP5/β-catenin signaling pathway on the pathogenesis of postmenopausal osteoporosis].
    Wang Y; Liu Y; Ma JX; Li BX; Li YK
    Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):769-72. PubMed ID: 22321352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop.
    Rawadi G; Vayssière B; Dunn F; Baron R; Roman-Roman S
    J Bone Miner Res; 2003 Oct; 18(10):1842-53. PubMed ID: 14584895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide-based mediated disruption of N-cadherin-LRP5/6 interaction promotes Wnt signaling and bone formation.
    Haÿ E; Buczkowski T; Marty C; Da Nascimento S; Sonnet P; Marie PJ
    J Bone Miner Res; 2012 Sep; 27(9):1852-63. PubMed ID: 22576936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of Lrp5 Signaling in Osteoblasts Sensitizes Male Mice to Diet-Induced Disturbances in Glucose Metabolism.
    Kim SP; Frey JL; Li Z; Goh BC; Riddle RC
    Endocrinology; 2017 Nov; 158(11):3805-3816. PubMed ID: 28938444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversing LRP5-dependent osteoporosis and SOST deficiency-induced sclerosing bone disorders by altering WNT signaling activity.
    Chang MK; Kramer I; Keller H; Gooi JH; Collett C; Jenkins D; Ettenberg SA; Cong F; Halleux C; Kneissel M
    J Bone Miner Res; 2014 Jan; 29(1):29-42. PubMed ID: 23901037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.